Company intelligence / Profile preview

Datavault

Beaverton, Oregon, United States

Ownership: Public · DVLT
Development stage: Other

Overview

Datavault AI provides AI-driven data infrastructure, data valuation, and secure monetization platforms that focus on life sciences, biotech, and healthcare. Their technology is used for digital twin modeling, data tokenization, and enables secure, compliant transactions of scientific and biotech data. No drug development or clinical programs; focus is on technology platform enabling biotech and pharma data applications.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Scilex Holding CompanyIBM WatsonXU.S. Department of Energy Brookhaven National Laboratory

Financials

Market cap: $110.9M
Total revenue: $917K
Enterprise value: $112M

Beyond the preview

Go deeper on Datavault.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Datavault.

Explore the full profile